A Placebo-Controlled Pilot Study of Adjunctive Olanzapine for Adolescents with Anorexia Nervosa
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of this study was to explore whether the addition of olanzapine versus placebo increases weight gain and improves psychological symptoms in adolescents with anorexia nervosa-restricting type who are participating in a comprehensive eating disorders treatment program. METHODS: Twenty underweight females participated in this 10-week, double-blind, placebo-controlled pilot study of olanzapine. The primary efficacy measure was change in percentage of median body weight measured at baseline and weeks 5 and 10. Secondary efficacy measures included clinician-rated and self-reported measures of psychological functioning measured at 2-week intervals and eating disorder symptoms measured at baseline and weeks 5 and 10 as well as laboratory assessments (including indirect calorimetry), which were also performed at baseline and weeks 5 and 10. A mixed models approach to repeated measures analysis of variance was utilized to detect any treatment-by-time interaction. RESULTS: Fifteen of 20 enrolled females (median age, 17.1 years; range, 12.3-21.8 years; mean body mass index, 16.3) completed this 10-week pilot study. Change in % median body weight did not differ between the treatment groups at midpoint or end of study. Both groups gained weight at a similar rate and had similar improvements in eating attitudes and behaviors, psychological functioning, and resting energy expenditure. A trend of increasing fasting glucose and insulin levels was found only in the olanzapine group at week 10. CONCLUSIONS: These preliminary findings do not support a role for adjunctive olanzapine for underweight adolescent females with anorexia nervosa-restricting type who are receiving standard care in an eating disorder treatment program (clinical trials.gov; no. NCT00592930).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115 · cited 3×
“On both measures of general psychopathology (HDRS and the Brief Psychiatric Rating Scale), the placebo group had elevated scores, indicating greater psychopathology, when compared with the olanzapine group at baseline; however, the group-by-time interactions were not significant.”
InfluentialNeurobiology of anorexia and bulimia nervosa
Kaye, W. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.037 · Cited by 625 · cited 1×
“The morbidity of this illness includes nutritional deficiencies, electrolyte and acid–base imbalances, dehydration, cardiac dysrrhythmias, and a hypometabolic state secondary to malnutrition (Kaye 2008).”
Anorexia nervosa treatment: A systematic review of randomized controlled trials
Bulik, C. M., Berkman, N. D., Brownley, K. A., Sedway, J. A., & Lohr, K. N. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20367 · Cited by 427
Olanzapine therapy in anorexia nervosa: psychobiological effects
Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., Ramaciotti, C., Bondi, E., Mellado, C., Borriello, R., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328080ca31 · Cited by 156 · cited 2×
“One found an effect for olanzapine on rate of weight gain (Bissada et al. 2008) and the other did not (Brambilla et al. 2007).”
Fluoxetine After Weight Restoration in Anorexia Nervosa: A Randomized Controlled Trial
Walsh, B. T., Kaplan, A. S., Attia, E., Olmsted, M., Parides, M., Carter, J. C., Pike, K. M., Devlin, M. J., Woodside, B., Roberto, C. A., et al. (2006) · JAMA · doi:10.1001/jama.295.22.2605 · Cited by 13 · cited 1×
“Psychopharmacological interventions examined thus far have had minimal success in reducing acute symptoms (Walsh et al. 2006) and improving long-term outcome (Bulik et al. 2007).”
Cited by
Eating Disorders in Children and Adolescents: State of the Art Review
Campbell, K., & Peebles, R. (2014) · Pediatrics · doi:10.1542/peds.2014-0194 · Cited by 382
Watson, H. J., & Bulik, C. M. (2013) · Psychological Medicine · doi:10.1017/s0033291712002620 · Cited by 339
Identification and Management of Eating Disorders in Children and Adolescents
Hornberger, L. L., Lane, M. A., THE COMMITTEE ON ADOLESCENCE, Hornberger, L. L., Lane, M., Breuner, C. C., Alderman, E. M., Grubb, L. K., Powers, M., Upadhya, K. K., et al. (2021) · Pediatrics · doi:10.1542/peds.2020-040279 · Cited by 300
Treasure, J., Zipfel, S., Micali, N., Wade, T., Stice, E., Claudino, A., Schmidt, U., Frank, G. K., Bulik, C. M., & Wentz, E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.74 · Cited by 285
Canadian practice guidelines for the treatment of children and adolescents with eating disorders
Couturier, J., Isserlin, L., Norris, M., Spettigue, W., Brouwers, M., Kimber, M., McVey, G., Webb, C., Findlay, S., Bhatnagar, N., et al. (2020) · Journal of Eating Disorders · doi:10.1186/s40337-020-0277-8 · Cited by 215
Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial
Attia, E., Steinglass, J. E., Walsh, B. T., Wang, Y., Wu, P., Schreyer, C., Wildes, J., Yilmaz, Z., Guarda, A. S., Kaplan, A. S., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18101125 · Cited by 211
Lock, J., & La Via, M. C. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.01.018 · Cited by 181
Psychopharmacological advances in eating disorders
Himmerich, H., & Treasure, J. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1383895 · Cited by 119
(2015) · PubMed · Cited by 93
Brewerton, T. D. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0287-6 · Cited by 48
Pharmakotherapie der Essstörungen—Ein Update
Bauman, T., & Voderholzer, U. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01804-y · Cited by 4
Metadata
- Authors
- Kafantaris, V., Leigh, E., Hertz, S., Berest, A., Schebendach, J., Sterling, W. M., Saito, E., Sunday, S., Higdon, C., Golden, N. H., & Malhotra, A. K.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2011-06
- Volume
- 21
- Issue
- 3
- Pages
- 207-212
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2059821636
- Cited by
- 145
- References
- 5
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.